Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results
Go back to Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results| (NASDAQ: CYCN) | Delayed: 3.59 +0.01 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $ | |||
| Open | $3.56 | 52 Week Low | $ | |||
| Day High | $3.59 | P/E | N/A | |||
| Day Low | $3.56 | EPS | $ | |||
| Volume | 1,527 | |||||

